|Values are valid only on day of printing.|
Determining in vitro quantitative antifungal susceptibility (minimum inhibitory concentration) of non-fastidious yeast
Testing may be warranted to aid in the management of certain circumstances, such as:
-Refractory oropharyngeal infections due to Candida species in patients who appear to be experiencing therapeutic failure with standard agents at standard doses
-Invasive infections due to Candida species when the utility of azole antifungal agents is uncertain (eg, when the infection is due to a non-Candida albicans organism)
|Test ID||Reporting Name||Available Separately||Always Performed|
|SYP||Susceptibility Yeast Panel||No, (Bill Only)||Yes|
When this test is ordered, Susceptibility Yeast Panel will be performed and charged. All yeast submitted will have susceptibility testing performed and billed as appropriate.
Minimum Inhibitory Concentration (MIC)
Antifungals included in the assay are: amphotericin B, anidulafungin, caspofungin fluconazole, 5-flucytosine, itraconazole, micafungin, posaconazole, and voriconazole.